Education
About Us
Working with TipRanks
Follow Us
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
| Sep 24 | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -194.32K | $ -179.68K | $ -164.87K | $ -152.36K |
| Operating Income | $ -42.00M | $ -36.73M | $ -33.32M | $ -23.53M | $ -17.71M |
| EBITDA | $ -38.64M | $ -36.73M | $ -32.88M | $ -22.88M | $ -17.38M |
| Net Income | $ -39.43M | $ -32.54M | $ -33.64M | $ -23.13M | $ -17.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.25M | $ 26.48M | $ 41.71M | $ 70.07M | $ 13.86M |
| Total Assets | $ 116.65M | $ 103.61M | $ 114.00M | $ 142.43M | $ 43.77M |
| Total Debt | $ 262.87K | $ 481.25K | $ 678.23K | $ 855.47K | $ 1.35M |
| Net Debt | $ -2.99M | $ -26.00M | $ -41.03M | $ -69.22M | $ -12.51M |
| Total Liabilities | $ 42.55M | $ 12.18M | $ 10.57M | $ 9.65M | $ 10.10M |
| Stockholders' Equity | $ 70.08M | $ 90.83M | $ 102.83M | $ 132.18M | $ 33.67M |
| Cash Flow | |||||
| Free Cash Flow | $ -28.20M | $ -29.06M | $ -28.36M | $ -64.26M | $ -16.93M |
| Operating Cash Flow | $ -28.20M | $ -29.06M | $ -28.36M | $ -24.25M | $ -16.93M |
| Investing Cash Flow | $ -5.00M | $ 0.00 | $ 0.00 | $ -40.01M | $ -1.83K |
| Financing Cash Flow | $ 9.97M | $ 13.83M | $ 0.00 | $ 120.47M | $ 22.90M |